Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-010159
Filing Date
2024-09-09
Accepted
2024-09-09 12:36:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27700
2 filename2.txt TEXT-EXTRACT 1199
  Complete submission text file 0000000000-24-010159.txt   40169
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filed for) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-281914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)